Genentech Xolair Average Cost Is $10,000 A Year; Mid-July Launch Planned

Genentech/Novartis' allergic asthma treatment Xolair will cost about $10,000 a year for the average patient at mid-July launch

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet